 | |
| Clinical data | |
|---|---|
| Trade names | Actazine, Quide, Psymod |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.021.194 |
| Chemical and physical data | |
| Formula | C24H30N2O2S |
| Molar mass | 410.58 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Piperacetazine (Quide) is anantipsychoticprodrug, most notably used forschizophrenia.[1] It is aphenothiazine derivative. Based on clinical trial data, it appears to have similar efficacy aschlorpromazine. However, very little research has been done since the 1970s, and it is not a commonly used drug today.[2]
The side effect profile of piperacetazine is similar to that of othertypical antipsychotics. The most common side effects of piperacetazine are dizziness, drowsiness,fainting,orthostatic hypotension, andextrapyramidal symptoms. Less common side effects include nausea, vomiting,bradycardia, euphoria, and headache. Rare side effects includeleukopenia,thrombocytopenia,galactorrhea,amenorrhea, seizures, urinary retention, andjaundice.[2]
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |
